Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-30 Sale |
2024-07-30 7:06 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
3,408 | $20.67 | $70,436 | 119,641 (Direct) |
View |
| 2024-07-30 Sale |
2024-07-30 7:06 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
2,920 | $20.67 | $60,350 | 91,387 (Direct) |
View |
| 2024-07-30 Sale |
2024-07-30 7:06 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,490 | $20.67 | $51,463 | 127,046 (Direct) |
View |
| 2024-07-01 Sale |
2024-07-01 6:35 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
5,760 | $20.81 | $119,837 | 108,384 (Direct) |
View |
| 2024-06-20 Sale |
2024-06-20 4:58 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
20,000 | $20.01 | $400,216 | 48,333 (Direct) |
View |
| 2024-06-13 Sale |
2024-06-13 6:39 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
1,864 | $17.02 | $31,721 | 114,144 (Direct) |
View |
| 2024-06-12 Sale |
2024-06-12 7:30 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
1,900 | $17.01 | $32,319 | 116,008 (Direct) |
View |
| 2024-06-05 Sale |
2024-06-05 6:01 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
400 | $17 | $6,801 | 117,908 (Direct) |
View |
| 2024-06-03 Sale |
2024-06-03 6:36 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
1,596 | $17.01 | $27,153 | 118,308 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-02 6:01 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
3,499 | $12.83 | $44,878 | 68,333 (Direct) |
View |
| 2024-04-30 Sale |
2024-04-30 6:33 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
1,387 | $12.04 | $16,703 | 108,035 (Direct) |
View |
| 2024-04-30 Sale |
2024-04-30 6:33 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
2,007 | $12.04 | $24,169 | 78,049 (Direct) |
View |
| 2024-04-30 Sale |
2024-04-30 6:33 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
1,513 | $12.04 | $18,220 | 49,307 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-16 7:20 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
6,812 | $10.02 | $68,223 | 68,333 (Direct) |
View |
| 2024-01-30 Sale |
2024-01-30 6:53 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
1,671 | $7.9902 | $13,352 | 116,234 (Direct) |
View |
| 2024-01-30 Sale |
2024-01-30 6:52 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
2,334 | $7.9902 | $18,649 | 80,056 (Direct) |
View |
| 2024-01-30 Sale |
2024-01-30 6:52 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
1,760 | $7.9902 | $14,063 | 50,820 (Direct) |
View |
| 2023-12-20 Sale |
2023-12-21 5:19 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
3,541 | $10 | $35,421 | 71,930 (Direct) |
View |
| 2023-12-19 Sale |
2023-12-20 4:55 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
10,906 | $10 | $109,093 | 75,471 (Direct) |
View |
| 2023-10-31 Sale |
2023-11-01 4:41 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
1,080 | $5.1974 | $5,613 | 132,352 (Direct) |
View |
| 2023-10-31 Sale |
2023-11-01 4:40 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
1,232 | $5.1974 | $6,403 | 52,580 (Direct) |
View |
| 2023-10-31 Sale |
2023-11-01 4:40 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,633 | $5.1974 | $8,487 | 82,390 (Direct) |
View |
| 2023-07-31 Sale |
2023-08-01 4:28 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
1,245 | $9.6547 | $12,020 | 133,432 (Direct) |
View |
| 2023-07-31 Sale |
2023-08-01 4:27 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,420 | $9.6547 | $13,710 | 53,785 (Direct) |
View |
| 2023-07-31 Sale |
2023-08-01 4:26 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,884 | $9.6547 | $18,189 | 84,023 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-30 Exercise |
2024-07-30 7:06 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
8,957 | $0 | 119,641 (Direct) |
View |
| 2024-07-30 Exercise |
2024-07-30 7:06 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
7,674 | $0 | 91,387 (Direct) |
View |
| 2024-07-30 Exercise |
2024-07-30 7:06 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
8,636 | $0 | 127,046 (Direct) |
View |
| 2024-07-17 Gift |
2024-07-18 4:06 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director |
54,027 | $0 | 0 (Direct) |
View |
| 2024-07-01 Exercise |
2024-07-01 6:35 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
5,760 | $1.86 | 108,384 (Direct) |
View |
| 2024-07-01 Exercise |
2024-07-01 6:35 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
5,760 | $0 | 108,384 (Direct) |
View |
| 2024-06-13 Exercise |
2024-06-13 6:39 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
1,864 | $1.86 | 114,144 (Direct) |
View |
| 2024-06-13 Exercise |
2024-06-13 6:39 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
1,864 | $0 | 114,144 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-12 7:30 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
1,900 | $1.86 | 116,008 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-12 7:30 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
1,900 | $0 | 116,008 (Direct) |
View |
| 2024-06-05 Exercise |
2024-06-05 6:01 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
400 | $1.86 | 117,908 (Direct) |
View |
| 2024-06-05 Exercise |
2024-06-05 6:01 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
400 | $0 | 117,908 (Direct) |
View |
| 2024-06-03 Exercise |
2024-06-03 6:36 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
1,596 | $1.86 | 118,308 (Direct) |
View |
| 2024-06-03 Exercise |
2024-06-03 6:36 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
1,596 | $0 | 118,308 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-20 7:26 pm |
N/A 2034-05-19 |
Nurix Therapeutics Inc. | NRIX | Silva Paul M Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-20 7:26 pm |
N/A 2034-05-19 |
Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-20 7:25 pm |
N/A 2034-05-19 |
Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-20 7:25 pm |
N/A 2034-05-19 |
Nurix Therapeutics Inc. | NRIX | Lacey David L. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-20 7:25 pm |
N/A 2034-05-19 |
Nurix Therapeutics Inc. | NRIX | Reinsdorf Judith A Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-20 7:25 pm |
N/A 2034-05-19 |
Nurix Therapeutics Inc. | NRIX | Saltzman Edward C Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-04-30 Exercise |
2024-04-30 6:33 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
4,886 | $0 | 108,035 (Direct) |
View |
| 2024-04-30 Exercise |
2024-04-30 6:33 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
5,206 | $0 | 78,049 (Direct) |
View |
| 2024-04-30 Exercise |
2024-04-30 6:33 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
3,924 | $0 | 49,307 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 07:23 am |
N/A 2034-02-12 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
195,000 | $0 | 195,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 07:23 am |
N/A 2034-02-12 |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
195,000 | $0 | 195,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 07:23 am |
N/A 2034-02-12 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
195,000 | $0 | 195,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 07:22 am |
N/A 2034-02-12 |
Nurix Therapeutics Inc. | NRIX | SANDS ARTHUR T President, CEO |
800,000 | $0 | 800,000 (Direct) |
View |
| 2024-01-30 Exercise |
2024-01-30 6:53 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
4,886 | $0 | 116,234 (Direct) |
View |
| 2024-01-30 Exercise |
2024-01-30 6:52 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
5,207 | $0 | 80,056 (Direct) |
View |
| 2024-01-30 Exercise |
2024-01-30 6:52 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
3,924 | $0 | 50,820 (Direct) |
View |
| 2023-10-30 Exercise |
2023-11-01 4:41 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
4,886 | $0 | 132,352 (Direct) |
View |
| 2023-10-30 Exercise |
2023-11-01 4:40 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer |
3,924 | $0 | 52,580 (Direct) |
View |
| 2023-10-30 Exercise |
2023-11-01 4:40 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
5,207 | $0 | 82,390 (Direct) |
View |
| 2023-07-30 Exercise |
2023-08-01 4:28 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
4,886 | $0 | 133,432 (Direct) |
View |
| 2023-07-30 Exercise |
2023-08-01 4:27 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
3,924 | $0 | 53,785 (Direct) |
View |
| 2023-07-30 Exercise |
2023-08-01 4:26 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
5,207 | $0 | 84,023 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-04 8:00 pm |
N/A 2033-05-03 |
Nurix Therapeutics Inc. | NRIX | Silva Paul M Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-04 7:58 pm |
N/A 2033-05-03 |
Nurix Therapeutics Inc. | NRIX | Saltzman Edward C Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-04 7:58 pm |
N/A 2033-05-03 |
Nurix Therapeutics Inc. | NRIX | Reinsdorf Judith A Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-04 7:57 pm |
N/A 2033-05-03 |
Nurix Therapeutics Inc. | NRIX | Lacey David L. Director |
25,000 | $0 | 25,000 (Direct) |
View |